New approaches in the management of advanced breast cancer &ndash; role of combination treatment with liposomal doxorubicin

Código QR

New approaches in the management of advanced breast cancer &ndash; role of combination treatment with liposomal doxorubicin

Iain RJ Macpherson, TR Jeffry EvansBeatson West of Scotland Cancer Centre, Glasgow, United KingdomAbstract: Metastatic breast cancer (MBC) remains a major cause of morbidity and mortality in women worldwide. For three decades doxorubicin, alone or in combination with other cytotoxic agents, has been...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Iain RJ Macpherson, TR Jeffry Evans
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/07d554b863344a4684d716ce24584f3f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
por: Franco YL, et al.
Publicado: (2018)

Emerging targeted combinations in the management of breast cancer
por: Lee RJ, et al.
Publicado: (2013)

Targeting &gamma;-secretase in breast cancer
por: Han J, et al.
Publicado: (2012)

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer
por: Merriam PA, et al.
Publicado: (2011)

Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer
por: Julia Foldi, et al.
Publicado: (2021)

Recent advances in the development of breast cancer vaccines
por: Milani A, et al.
Publicado: (2014)

The network of pluripotency, epithelial–mesenchymal transition, and prognosis of breast cancer
por: Voutsadakis IA
Publicado: (2015)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
por: Allan Lipton
Publicado: (2011)

Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
por: Ayoub NM, et al.
Publicado: (2019)

The AURORA pilot study for molecular screening of patients with advanced breast cancer–a study of the breast international group
por: Marion Maetens, et al.
Publicado: (2017)

Does Veritas&reg; play a role in breast reconstruction? a case report
por: De Vita F, et al.
Publicado: (2011)

Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective
por: Machado M, et al.
Publicado: (2012)

Are there efficacious treatments for treating the fatigue–sleep disturbance–depression symptom cluster in breast cancer patients? A Rapid Evidence Assessment of the Literature (REAL©)
por: Jain S, et al.
Publicado: (2015)

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
por: Allen Li, et al.
Publicado: (2021)

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
por: Stephen Johnston, et al.
Publicado: (2021)

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
por: Hurvitz SA, et al.
Publicado: (2012)

The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data
por: Natansh D. Modi, et al.
Publicado: (2021)

Circulating tumor DNA dynamics in advanced breast cancer treated with CDK4/6 inhibition and endocrine therapy
por: Olga Martínez-Sáez, et al.
Publicado: (2021)

IL-1B drives opposing responses in primary tumours and bone metastases; harnessing combination therapies to improve outcome in breast cancer
por: Claudia Tulotta, et al.
Publicado: (2021)

Adolescent alcohol, nuts, and fiber: combined effects on benign breast disease risk in young women
por: Catherine S. Berkey, et al.
Publicado: (2020)

Nivolumab in combination with cabozantinib for metastatic triple-negative breast cancer: a phase II and biomarker study
por: Romualdo Barroso-Sousa, et al.
Publicado: (2021)

The incidence rate of female breast cancer in Saudi Arabia: an observational descriptive epidemiological analysis of data from Saudi Cancer Registry 2001–2008
por: Alghamdi IG, et al.
Publicado: (2013)

Epithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor–binding protein 3?
por: Zielinska HA, et al.
Publicado: (2015)

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
por: Lillian M. Smyth, et al.
Publicado: (2021)

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
por: Andrea Gombos, et al.
Publicado: (2021)

Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
por: Jeffrey P. Solzak, et al.
Publicado: (2017)

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
por: Haxho F, et al.
Publicado: (2014)

The efficacy of the combination of eribulin and trastuzumab in advanced HER2-positive breast cancer: the results of Russian observational study
por: Elena I. Kovalenko, et al.
Publicado: (2020)

Graphic tobacco warning labels – an improper solution?
por: Salvi JD
Publicado: (2014)

Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells
por: Chatterjee S, et al.
Publicado: (2015)

Palliative care: needs of advanced breast cancer patients
por: Cherny NI, et al.
Publicado: (2018)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
por: Tom Walsh, et al.
Publicado: (2021)

Breast cancer risk in a rapidly aging population: advances and approaches to study the aging tissue microenvironment
por: Greco SJ
Publicado: (2019)

PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting
por: Laura Pizzuti, et al.
Publicado: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou P, et al.
Publicado: (2015)

Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
por: Goldfinger LE, et al.
Publicado: (2013)

Dormancy in breast cancer
por: Banys M, et al.
Publicado: (2012)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
por: Nehmat Houssami
Publicado: (2021)

Epigenomics and immunotherapeutic advances in pediatric brain tumors
por: Malak Abedalthagafi, et al.
Publicado: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
por: Jennifer Xiao, et al.
Publicado: (2021)